The Valley Desk

NCT02545868 · Interventional trial

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

Overall registry status Completed

Phase 3

Conditions Multiple Sclerosis, Relapsing-Remitting

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov